from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3815c/-

LFCtreatmentdescriptionclass of inhibitor

-1.592

Amikacinug/mL Amikacintranslation

-2.102

Cap5-10ug/mL Capreomycintranslation

-1.402

Rox10-50 ug/mL Roxithromycintranslation

-0.126

SM2-5 ug/mL Streptomycintranslation

-2.180

Tet5-10 ug/mL Tetracyclinetranslation

-1.005

Rif0.2-5ug/mL Rifampicintranscription

-1.033

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.526

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.397

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.282

CPZ10-50 ug/mL Chlorpromazinerespiration

1.120

Clofazimine10-13 ug/mL Clofaziminerespiration

0.255

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.601

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.037

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.135

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.225

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.645

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.485

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.964

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.777

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.407

KCN5-20 ug/mL Potassium cyaniderespiration

1.277

NaN30.2-2 mM Sodium aziderespiration

0.952

Nigericin50 uM Nigericinrespiration

0.376

TRC10-150 ug/mL Triclosanrespiration

1.357

TRZ10-25 ug/mL Thioridazinerespiration

-1.936

Valinomycin0.5-10 uM Valinomycinrespiration

0.003

ZnSO42 mM ZnSO4respiration

0.929

menadione6-10 ug/mL Menadionerespiration

0.362

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.313

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.142

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.127

NRP_1Non-replicating persistence stage 1dosRassociated

-0.195

Amp0.2mg/mL AmpicillincellWall

-0.091

Cephalexin20-100 ug/mL CephalexincellWall

-0.050

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.957

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.281

EMB10-20 ug/mL EthambutolcellWall

0.122

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.026

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.347

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.249

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.574

BZA0.12 mg/mL BenzamidearomaticAmides

-0.200

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.242

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.092

H2O24 mM hydrogen peroxideDNAdamaging

0.351

Levo10 ug/mL LevofloxacinDNAdamaging

-0.747

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.948

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.531

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.039

UVUV-irradiationDNAdamaging

0.828

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.455

Antimycin12.5-50 ug/mL Antimycin A?

-0.405

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.155

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.413

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.744

PA8240.2-2 ug/mL PA-824?

1.695

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.482

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.130

Verapamil50 uM Verapamil?

-0.476

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.479

methoxatin10-20 ug/mL Methoxatin?